Types and grades of non-Hodgkin lymphoma
Skin (cutaneous) lymphoma is a rare type of non-Hodgkin lymphoma (NHL).
NHL is a type of blood cancer that affects white blood cells called . It is a cancer of the .
Skin lymphoma is also called cutaneous lymphoma. There are 2 main types of skin lymphoma:
cutaneous T cell lymphoma (CTCL)
cutaneous B cell lymphoma (CBCL)
CTCL is the most common type of skin lymphoma. CBCL is more unusual. This page is about CTCL.
The most common types of CTCL are mycosis fungoides (MF) and Sezary syndrome.
Skin (cutaneous) lymphoma is a rare type of non-Hodgkin lymphoma (NHL).
Lymphoma develops when white blood cells called lymphocytes grow out of control. They move around your body in your blood and your lymphatic system.
The lymphatic system is an important part of our immune system. It has tubes that branch through all parts of the body.
These tubes are called lymph vessels or lymphatic vessels and they carry a straw coloured liquid called lymph. This liquid circulates around the body tissues. It contains a high number of white blood cells (lymphocytes) which fight infection.
There are 2 types of lymphocytes:
T cells
B cells
In cutaneous lymphoma the T cells or B cells grow out of control within the skin. There are 2 main types of skin lymphoma:
cutaneous T cell lymphoma (CTCL) starts in the T cells of the skin
cutaneous B cell lymphoma (CBCL) starts in the B cells of the skin
CTCL is the most common type of skin lymphoma. It causes flat red patches on the skin that look like eczema and can be itchy. Several parts of the body can be affected.
CBCL is a more unusual type. People tend to have lumps on their skin in 1 or 2 areas, rather than affecting all of the body.
CTCL is rare. Only around 150 people are diagnosed with CTCL in the UK each year.
Many types of CTCL start as flat red patches on the skin, which can sometimes be itchy. With darker skin, the patches may appear lighter or darker than the surrounding skin.
In the early stages, the skin patches can look like other common conditions such as eczema or psoriasis.
Doctors diagnose CTCL by taking a sample of the affected skin. This is called a biopsy. A specialist doctor (pathologist) examines it under a microscope, looking for cancerous T cells.
Diagnosing skin lymphoma can be difficult. So it is not unusual to have more than one biopsy over a number of weeks or months.
If your doctor diagnoses lymphoma, you might have further tests. These might include:
blood tests
a or
a
You might see different types of doctors during your diagnosis and treatment. There will be a team of people ( ) from different hospital departments involved in your diagnosis. This might include:
a dermatologist (specialist skin doctor)
a haematologist (a specialist doctor who treats diseases affecting the blood)
an oncologist (a cancer specialist)
Grade
Grade describes how the cells look under a microscope. Your grade tells the doctor how quickly the lymphoma is likely to grow and spread. Doctors put NHL into 2 grades:
low grade (slow growing)
high grade (fast growing)
There are different types of CTCL. Most are slow growing (low grade) but some can be fast growing (high grade).
Knowing the type and grade of the lymphoma helps doctors decide on the best treatment and how soon it should start. For some very slow growing types of CTCL, treatment might not need to start straight away.
Types
The most common types of CTCL are mycosis fungoides (pronounced my-coh-sis fun-goyd-eez) and Sezary syndrome.
Mycosis fungoides (MF) is a very slow growing (low grade) type of CTCL.
MF often starts as an irregular shaped area of dry or scaly skin. It can appear as a single patch or in several areas of the body. The patches can appear anywhere on the body but are more often found on the chest, , back and buttocks. These abnormal areas of skin might form scaly raised patches, called plaques.
In a small number of people, raised lumps (tumours) can appear. Rarely, the disease becomes more advanced and the skin appears red, swollen and sore all over. This is called erythrodermic mycosis fungoides. In a few cases the cancerous cells can spread to the lymph nodes or organs such as the liver.
A rare type of CTCL is called Sezary syndrome. It is closely related to mycosis fungoides but most or all of the skin is covered in a red itchy rash. There are also cancerous T cells (called Sezary cells) in the blood.
Sezary syndrome is a faster growing (high grade) type of CTCL. People with Sezary syndrome often have a weakened immune system. So there is an increased risk of infection.
There are some other rare subtypes of CTCL. Your doctor will tell you more about what type you have. And they can tell you whether your subtype is usually slow or fast growing.
The stage shows how much of the skin is affected by lymphoma, and whether it has spread to the lymph nodes or other body organs.
There are 4 main stages for mycosis fungoides. Sezary syndrome is an advanced stage because it is a widespread disease at diagnosis.
Stage 1 only affects the skin (in patches or plaques). This stage is divided into two groups:
stage 1A means that the lymphoma affects less than 10% of the skin
stage 1B means that the patches or plaques have become more widespread, affecting more than 10% of the skin
As a rough guide, 10% of your skin is about the same amount of skin as 10 palms of your hand.
Stage 2 is divided into 2 groups:
stage 2A means there are patches or plaques on the skin and the lymph nodes are swollen, but there are no cancerous T cells there
stage 2B means there are one or more lumps (tumours) in the skin
Stage 3 is divided into 2 groups:
stage 3A means that most of the skin (more than 80%) appears red and sore (erythrodermic mycosis fungoides)
stage 3B is the same as 3A, but there are some cancerous T cells (Sezary cells) in the blood
Stage 4 is divided into 3 groups:
stage 4A1 means there are high numbers of cancerous T cells (Sezary cells) in the blood (Sezary syndrome)
stage 4A2 means there are cancerous T cells in the lymph nodes
stage 4B means the cancer has spread to other organs of the body, such as the liver or spleen
SWAT score
You might also hear your doctor talking about a SWAT score. SWAT stands for the Severity Weighted Assessment Tool (SWAT). Your doctor examines each area of lymphoma. They measure how much of your skin is affected by the lymphoma and calculate a score. This is different to your stage. Your doctor might use this score to monitor your CTCL.
The aim of treatment is to control your skin lymphoma and symptoms for as long as possible, and with as few side effects as possible.
Your treatment depends on:
the type of skin lymphoma you have
how advanced it is (the stage)
your symptoms
your general health
You often need to try more than one type of treatment over your life time. You might have a single treatment, or several treatments together.
If you have stage 1 or 2A mycosis fungoides (MF), you may not start treatment straight away. Your doctor monitors you closely. This is called active monitoring or watch and wait. You start treatment if your lymphoma gets worse, or if you have symptoms that are bothering you.
Starting treatment earlier will not affect your outlook (prognosis) or how fast the MF grows. Early stage treatment is more about controlling any symptoms you have.
You might have one or more of the following treatments:
treatments applied directly to your skin (topical treatment) - these include steroid or creams
light treatments (phototherapy) - these include psoralen ultraviolet light treatment (PUVA ) and narrow band UVB treatment
to treat small areas of skin lymphoma (localised radiotherapy)
If you have stage 2B or stage 4 MF, you might have a type of radiotherapy called total skin electron beam therapy (TSEBT) as your first treatment.
For stage 3 MF you might have a type of light treatment called extracorporeal photopheresis (ECP).
If your MF is above stage 1a and not responding to , you might also have one of the following drug treatments. You either have these on their own or together with other treatments:
an drug called interferon
a drug called bexarotene
a drug (for stage 3 or 4)
Lymphoma that does not go away with treatment is called refractory lymphoma. Lymphoma that comes back after treatment is called relapsed disease.
Treatment can control MF very well. But it is common for MF to relapse
For stage 1 and 2A MF that comes back you might have:
a type of radiotherapy called total skin electron beam therapy (TSEBT)
drug treatment with interferon or bexarotene - you have these on their own or together with light treatments (phototherapy)
For more advanced MF (stage 2B or above) you might have:
a targeted immunotherapy drug such as brentuximab or mogamulizumab
chemotherapy
You might have a type of radiotherapy called total skin electron beam therapy (TSEBT) for stage 3 MF that comes back.
You might have these a single treatment, or several treatments together:
a type of light treatment called extracorporeal photopheresis (ECP) - you have it on its own or with either interferon, methotrexate or bexarotene
PUVA light treatment with either interferon, methotrexate or bexarotene
a chemotherapy drug treatment, usually with just one drug
If treatment doesn't work, or your sezary syndrome gets worse again, you might have:
a targeted immunotherapy drug such as brentuximab or mogamulizumab
chemotherapy drug treatment
a stem cell transplant
We have more information about these treatments below.
Doctors are testing newer treatments for cutaneous T cell lymphomas. They are looking for treatments that can control it for longer, and hopefully get rid of it altogether in more people. They are looking at different drug treatments including:
mogamulizumab, together with radiotherapy.
pembrolizumab and radiotherapy
Histone deacetylase (HDAC) inhibitors such as resminostat
Read more about research into NHL
Skin lymphoma and its treatment can cause physical problems. Problems might include itching or burning skin. And you might develop infections. Ask your consultant or specialist nurse for advice about how to look after your skin and ways to make it more comfortable. They will be able to suggest treatments to help with itching or burning.
It can be difficult coping with a rare type of cancer as you may not meet many people in a similar situation. Other people might notice your skin and it could make you conscious of your condition. This can affect your mood or confidence.
CTCL can affect your sex life. The lymphoma patches and rash can be uncomfortable and you might not want anyone close to you or touching you. Changes in your appearance might also affect how you feel about having sex.
Try not to feel embarrassed about discussing sexual problems with your specialist nurse or doctor. They are used to answering questions about sex and talking about these changes might be helpful. Discuss your feelings and any worries with your partner too. Your partner could go with you if you decide to have a chat with your doctor or nurse.
Other support for people with CTCL
You could also ask if there are any support groups at your hospital or within your local area. There are also charities, such as the Lymphoma Association who can provide support and information.
It might help to let friends and family know if you are finding it difficult to cope. Talking about how you feel can help. Some people decide to have counselling.
Last reviewed: 19 Mar 2024
Next review due: 19 Mar 2027
Non-Hodgkin lymphoma (NHL) is a type of blood cancer that affects white blood cells called lymphocytes. It's the 6th most common type of cancer in adults.
There are many different types of non-Hodgkin lymphoma (NHL). Doctors also give NHL a grade, depending on how quickly it is likely to grow.
Your treatment depends on the type and stage of your NHL. Common treatments include chemotherapy, targeted and immunotherapy drugs, radiotherapy and a stem cell transplant.
Practical and emotional support is available to help you cope with non-Hodgkin lymphoma.
There are many cancer drugs, cancer drug combinations and they have individual side effects.

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.